▶ 調査レポート

世界の抗体薬物コンジュゲート産業2020-2026

• 英文タイトル:Global Antibody-drug Conjugates Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが調査・発行した産業分析レポートです。世界の抗体薬物コンジュゲート産業2020-2026 / Global Antibody-drug Conjugates Industry Research Report, Growth Trends and Competitive Analysis 2020-2026 / D0MA3010979資料のイメージです。• レポートコード:D0MA3010979
• 出版社/出版日:QYResearch / 2020年1月
• レポート形態:英文、PDF、111ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:製薬・医療
• 販売価格(消費税別)
  Single User¥553,700 (USD4,900)▷ お問い合わせ
  Multi User¥830,550 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,107,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当リサーチレポートでは、抗体薬物コンジュゲートの世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、抗体薬物コンジュゲートのグローバル市場動向、メーカー別競争状況、種類別市場規模(アドセトリス、カドシラ)、用途別市場規模(乳がん、リンパ腫)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。
・レポート概要
・グローバル市場動向
・メーカー別競争状況
・抗体薬物コンジュゲートの種類別市場2015-2026:アドセトリス、カドシラ
・抗体薬物コンジュゲートの用途別市場2015-2026:乳がん、リンパ腫
・抗体薬物コンジュゲートの北米市場分析
・抗体薬物コンジュゲートのアジア市場分析
・抗体薬物コンジュゲートの中南米市場分析
・抗体薬物コンジュゲートの中東・アフリカ市場分析
・関連企業情報:ImmunoGen、Seattle Genetics、Roche、Takeda
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.
North America ranks the top in terms of global market size of Antibody Drug Conjugate, it consists of 59.12% of the international market in 2016. Europe comes the second, with 27.70% of the global market. Asia Pacific consists of 6.54%of the Antibody Drug Conjugate market in the same year.
In 2019, the global Antibody-drug Conjugates market size was US$ 2646.2 million and is forecast to US$ 3262.1 million in 2026, growing at a CAGR of 3.0% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Antibody-drug Conjugates.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Antibody-drug Conjugates market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Antibody-drug Conjugates market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Antibody-drug Conjugates market. Readers of the report can become informed about current and future trends of the global Antibody-drug Conjugates market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Antibody-drug Conjugates markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Antibody-drug Conjugates market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Antibody-drug Conjugates market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Antibody-drug Conjugates market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Antibody-drug Conjugates market is segmented into
Adcetris
Kadcyla

Market Segment by Application, the Antibody-drug Conjugates market is segmented into
Breast Cancer
Lymphoma

This report includes the following manufacturers; we can also add the other companies as you want.
ImmunoGen
Seattle Genetics
Roche
Takeda

The study objectives are:
To analyze and research the global Antibody-drug Conjugates status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Antibody-drug Conjugates manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Antibody-drug Conjugates are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

レポート目次

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Antibody-drug Conjugates Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Antibody-drug Conjugates Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Adcetris
1.3.3 Kadcyla
1.4 Market Segment by Application
1.4.1 Global Antibody-drug Conjugates Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Breast Cancer
1.4.3 Lymphoma
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Antibody-drug Conjugates Revenue (2015-2026)
2.1.1 Global Antibody-drug Conjugates Revenue (2015-2026)
2.1.2 Global Antibody-drug Conjugates Sales (2015-2026)
2.2 Antibody-drug Conjugates Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Antibody-drug Conjugates Sales by Regions (2015-2020)
2.2.2 Global Antibody-drug Conjugates Revenue by Regions (2015-2020)
2.3 Global Top Antibody-drug Conjugates Regions (Countries) Ranking by Market Size
2.4 Antibody-drug Conjugates Industry Trends
2.4.1 Antibody-drug Conjugates Market Top Trends
2.4.2 Market Drivers
2.4.3 Antibody-drug Conjugates Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Antibody-drug Conjugates Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Antibody-drug Conjugates Manufacturers by Sales (2015-2020)
3.1.1 Global Antibody-drug Conjugates Sales by Manufacturers (2015-2020)
3.1.2 Global Antibody-drug Conjugates Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Antibody-drug Conjugates Sales in 2019
3.2 Global Top Manufacturers Antibody-drug Conjugates by Revenue
3.2.1 Global Antibody-drug Conjugates Revenue by Manufacturers (2015-2020)
3.2.2 Global Antibody-drug Conjugates Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antibody-drug Conjugates Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody-drug Conjugates as of 2019)
3.4 Global Antibody-drug Conjugates Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Antibody-drug Conjugates Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Antibody-drug Conjugates Market
3.7 Key Manufacturers Antibody-drug Conjugates Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Antibody-drug Conjugates Historic Market Review by Type (2015-2020)
4.1.2 Global Antibody-drug Conjugates Sales Market Share by Type (2015-2020)
4.1.3 Global Antibody-drug Conjugates Revenue Market Share by Type (2015-2020)
4.1.4 Antibody-drug Conjugates Price by Type (2015-2020)
4.1 Global Antibody-drug Conjugates Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Antibody-drug Conjugates Sales Forecast by Type (2021-2026)
4.2.3 Global Antibody-drug Conjugates Revenue Forecast by Type (2021-2026)
4.2.4 Antibody-drug Conjugates Price Forecast by Type (2021-2026)

5 Global Antibody-drug Conjugates Market Size by Application
5.1 Global Antibody-drug Conjugates Historic Market Review by Application (2015-2020)
5.1.2 Global Antibody-drug Conjugates Sales Market Share by Application (2015-2020)
5.1.3 Global Antibody-drug Conjugates Revenue Market Share by Application (2015-2020)
5.1.4 Antibody-drug Conjugates Price by Application (2015-2020)
5.2 Global Antibody-drug Conjugates Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Antibody-drug Conjugates Sales Forecast by Application (2021-2026)
5.2.3 Global Antibody-drug Conjugates Revenue Forecast by Application (2021-2026)
5.2.4 Antibody-drug Conjugates Price Forecast by Application (2021-2026)

6 North America
6.1 North America Antibody-drug Conjugates Breakdown Data by Company
6.2 North America Antibody-drug Conjugates Breakdown Data by Type
6.3 North America Antibody-drug Conjugates Breakdown Data by Application
6.4 North America Antibody-drug Conjugates Breakdown Data by Countries
6.4.1 North America Antibody-drug Conjugates Sales by Countries
6.4.2 North America Antibody-drug Conjugates Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Antibody-drug Conjugates Breakdown Data by Company
7.2 Europe Antibody-drug Conjugates Breakdown Data by Type
7.3 Europe Antibody-drug Conjugates Breakdown Data by Application
7.4 Europe Antibody-drug Conjugates Breakdown Data by Countries
7.4.1 Europe Antibody-drug Conjugates Sales by Countries
7.4.2 Europe Antibody-drug Conjugates Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Antibody-drug Conjugates Breakdown Data by Company
8.2 Asia Pacific Antibody-drug Conjugates Breakdown Data by Type
8.3 Asia Pacific Antibody-drug Conjugates Breakdown Data by Application
8.4 Asia Pacific Antibody-drug Conjugates Breakdown Data by Regions
8.4.1 Asia Pacific Antibody-drug Conjugates Sales by Regions
8.4.2 Asia Pacific Antibody-drug Conjugates Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Antibody-drug Conjugates Breakdown Data by Company
9.2 Latin America Antibody-drug Conjugates Breakdown Data by Type
9.3 Latin America Antibody-drug Conjugates Breakdown Data by Application
9.4 Latin America Antibody-drug Conjugates Breakdown Data by Countries
9.4.1 Latin America Antibody-drug Conjugates Sales by Countries
9.4.2 Latin America Antibody-drug Conjugates Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Antibody-drug Conjugates Breakdown Data by Type
10.2 Middle East and Africa Antibody-drug Conjugates Breakdown Data by Application
10.3 Middle East and Africa Antibody-drug Conjugates Breakdown Data by Countries
10.3.1 Middle East and Africa Antibody-drug Conjugates Sales by Countries
10.3.2 Middle East and Africa Antibody-drug Conjugates Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 ImmunoGen
11.1.1 ImmunoGen Corporation Information
11.1.2 ImmunoGen Business Overview and Total Revenue (2019 VS 2018)
11.1.3 ImmunoGen Antibody-drug Conjugates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 ImmunoGen Antibody-drug Conjugates Products and Services
11.1.5 ImmunoGen SWOT Analysis
11.1.6 ImmunoGen Recent Developments
11.2 Seattle Genetics
11.2.1 Seattle Genetics Corporation Information
11.2.2 Seattle Genetics Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Seattle Genetics Antibody-drug Conjugates Products and Services
11.2.5 Seattle Genetics SWOT Analysis
11.2.6 Seattle Genetics Recent Developments
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Roche Antibody-drug Conjugates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Roche Antibody-drug Conjugates Products and Services
11.3.5 Roche SWOT Analysis
11.3.6 Roche Recent Developments
11.4 Takeda
11.4.1 Takeda Corporation Information
11.4.2 Takeda Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Takeda Antibody-drug Conjugates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Takeda Antibody-drug Conjugates Products and Services
11.4.5 Takeda SWOT Analysis
11.4.6 Takeda Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Antibody-drug Conjugates Sales Channels
12.2.2 Antibody-drug Conjugates Distributors
12.3 Antibody-drug Conjugates Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Antibody-drug Conjugates Sales Forecast (2021-2026)
13.1.1 Global Antibody-drug Conjugates Sales Forecast by Regions (2021-2026)
13.1.2 Global Antibody-drug Conjugates Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Antibody-drug Conjugates Sales Forecast (2021-2026)
13.2.2 North America Antibody-drug Conjugates Revenue Forecast (2021-2026)
13.2.3 North America Antibody-drug Conjugates Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Antibody-drug Conjugates Sales Forecast (2021-2026)
13.3.2 Europe Antibody-drug Conjugates Revenue Forecast (2021-2026)
13.3.3 Europe Antibody-drug Conjugates Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Antibody-drug Conjugates Sales Forecast (2021-2026)
13.4.2 Asia Pacific Antibody-drug Conjugates Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Antibody-drug Conjugates Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Antibody-drug Conjugates Sales Forecast (2021-2026)
13.5.2 Latin America Antibody-drug Conjugates Revenue Forecast (2021-2026)
13.5.3 Latin America Antibody-drug Conjugates Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Antibody-drug Conjugates Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Antibody-drug Conjugates Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Antibody-drug Conjugates Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Antibody-drug Conjugates Key Market Segments
Table 2. Ranking of Global Top Antibody-drug Conjugates Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antibody-drug Conjugates Market Size Growth Rate by Type 2021-2026 (Kg) & (Million US$)
Table 4. Major Manufacturers of Adcetris
Table 5. Major Manufacturers of Kadcyla
Table 6. Global Antibody-drug Conjugates Market Share by Application 2019-2025 (Kg)
Table 7. Global Antibody-drug Conjugates Market Size by Regions 2015-2020 (Kg) & (Million US$)
Table 8. Global Antibody-drug Conjugates Sales by Regions 2015-2020 (Kg)
Table 9. Global Antibody-drug Conjugates Sales Market Share by Regions 2015-2020
Table 10. Global Antibody-drug Conjugates Revenue by Regions 2015-2020 (Million US$)
Table 11. Global Antibody-drug Conjugates Revenue Market Share by Regions 2015-2020
Table 12. Top Antibody-drug Conjugates Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 13. Market Top Trends
Table 14. Antibody-drug Conjugates Key Drivers: Impact Analysis (2021-2026)
Table 15. Antibody-drug Conjugates Key Challenges
Table 16. Main Points Interviewed from Key Antibody-drug Conjugates Players: Views for Future
Table 17. Global Antibody-drug Conjugates Sales by Manufacturers (2015-2020) (Kg)
Table 18. Global Antibody-drug Conjugates Sales Share by Manufacturers (2015-2020)
Table 19. Antibody-drug Conjugates Revenue by Manufacturers (2015-2020) (Million US$)
Table 20. Antibody-drug Conjugates Revenue Share by Manufacturers (2015-2020)
Table 21. Global Antibody-drug Conjugates Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody-drug Conjugates as of 2019)
Table 23. Key Manufacturers Antibody-drug Conjugates Average Selling Price (ASP) (2015-2020) (USD/Kg)
Table 24. Key Manufacturers Antibody-drug Conjugates Plants/Factories Distribution
Table 25. Key Manufacturers Antibody-drug Conjugates Area Served
Table 26. Date of Key Manufacturers Enter into Antibody-drug Conjugates Market
Table 27. Key Manufacturers Antibody-drug Conjugates Product Type
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Adcetris Sales and Revenue (2015-2020) (Kg) & (Million US$)
Table 30. Global Kadcyla Sales and Revenue (2015-2020) (Kg) & (Million US$)
Table 31. Global Antibody-drug Conjugates Sales (Kg) by Type (2015-2020)
Table 32. Global Antibody-drug Conjugates Sales Share by Type (2015-2020)
Table 33. Global Antibody-drug Conjugates Revenue (US$ Million) Market Share by Type (2015-2020)
Table 34. Global Antibody-drug Conjugates Price (Kg) by Type (2015-2020)
Table 35. Global Antibody-drug Conjugates Sales (Kg) by Type (2021-2026)
Table 36. Global Antibody-drug Conjugates Sales Share by Type (2021-2026)
Table 37. Global Antibody-drug Conjugates Revenue (US$ Million) Market Share by Type (2021-2026)
Table 38. Global Antibody-drug Conjugates Revenue Share by Type (2021-2026)
Table 39. Global Antibody-drug Conjugates Price (Kg) by Type (2021-2026)
Table 40. Global Antibody-drug Conjugates Sales (Kg) by Application (2015-2020)
Table 41. Global Antibody-drug Conjugates Sales Share by Application (2015-2020)
Table 42. Global Antibody-drug Conjugates Revenue (US$ Million) Market Share by Application (2015-2020)
Table 43. Global Antibody-drug Conjugates Price by Application 2015-2020 (USD/Kg)
Table 44. Global Antibody-drug Conjugates Sales by Application (2015-2020) (Kg)
Table 45. Global Antibody-drug Conjugates Sales Share by Application (2015-2020)
Table 46. Global Antibody-drug Conjugates Revenue (US$ Million) Market Share by Application (2021-2026)
Table 47. Global Antibody-drug Conjugates Revenue Share by Application (2021-2026)
Table 48. Global Antibody-drug Conjugates Price (Kg) by Application (2021-2026)
Table 49. North America Antibody-drug Conjugates Sales by Company (2015-2020) (Kg)
Table 50. North America Antibody-drug Conjugates Sales Market Share by Company (2015-2020)
Table 51. North America Antibody-drug Conjugates Sales by Type (2015-2020) (Kg)
Table 52. North America Antibody-drug Conjugates Sales Market Share by Type (2015-2020)
Table 53. North America Antibody-drug Conjugates Sales by Application (2015-2020) (Kg)
Table 54. North America Antibody-drug Conjugates Sales Market Share by Application (2015-2020)
Table 55. North America Antibody-drug Conjugates Sales by Countries (2015-2020) (Kg)
Table 56. North America Antibody-drug Conjugates Sales Market Share by Countries (2015-2020)
Table 57. North America Antibody-drug Conjugates Revenue by Countries (2015-2020) (Million US$)
Table 58. North America Antibody-drug Conjugates Revenue Market Share by Countries (2015-2020)
Table 59. Europe Antibody-drug Conjugates Sales by Company (2015-2020) (Kg)
Table 60. Europe Antibody-drug Conjugates Sales Market Share by Company (2015-2020)
Table 61. Europe Antibody-drug Conjugates Sales by Type (2015-2020) (Kg)
Table 62. Europe Antibody-drug Conjugates Sales Market Share by Type (2015-2020)
Table 63. Europe Antibody-drug Conjugates Sales by Application (2015-2020) (Kg)
Table 64. Europe Antibody-drug Conjugates Sales Market Share by Application (2015-2020)
Table 65. Europe Antibody-drug Conjugates Sales by Countries (2015-2020) (Kg)
Table 66. Europe Antibody-drug Conjugates Sales Market Share by Countries (2015-2020)
Table 67. Europe Antibody-drug Conjugates Revenue by Countries (2015-2020) (Million US$)
Table 68. Europe Antibody-drug Conjugates Revenue Market Share by Countries (2015-2020)
Table 69. Asia Pacific Antibody-drug Conjugates Sales by Regions (2015-2020) (Kg)
Table 70. Asia Pacific Antibody-drug Conjugates Sales Market Share by Regions (2015-2020)
Table 71. Asia Pacific Antibody-drug Conjugates Sales by Type (2015-2020) (Kg)
Table 72. Asia Pacific Antibody-drug Conjugates Sales Market Share by Type (2015-2020)
Table 73. Asia Pacific Antibody-drug Conjugates Sales by Application (2015-2020) (Kg)
Table 74. Asia Pacific Antibody-drug Conjugates Sales Market Share by Application (2015-2020)
Table 75. Asia Pacific Antibody-drug Conjugates Sales by Countries (2015-2020) (Kg)
Table 76. Asia Pacific Antibody-drug Conjugates Sales Market Share by Regions (2015-2020)
Table 77. Asia Pacific Antibody-drug Conjugates Revenue by Regions (2015-2020) (Million US$)
Table 78. Asia Pacific Antibody-drug Conjugates Revenue Market Share by Regions (2015-2020)
Table 79. Latin America Antibody-drug Conjugates Sales by Company (2015-2020) (Kg)
Table 80. Latin America Antibody-drug Conjugates Sales Market Share by Company (2015-2020)
Table 81. Latin America Antibody-drug Conjugates Sales by Type (2015-2020) (Kg)
Table 82. Latin America Antibody-drug Conjugates Sales Market Share by Type (2015-2020)
Table 83. Latin America Antibody-drug Conjugates Sales by Application (2015-2020) (Kg)
Table 84. Latin America Antibody-drug Conjugates Sales Market Share by Application (2015-2020)
Table 85. Latin America Antibody-drug Conjugates Sales by Countries (2015-2020) (Kg)
Table 86. Latin America Antibody-drug Conjugates Sales Market Share by Countries (2015-2020)
Table 87. Latin America Antibody-drug Conjugates Revenue by Countries (2015-2020) (Million US$)
Table 88. Latin America Antibody-drug Conjugates Revenue Market Share by Countries (2015-2020)
Table 89. Middle East and Africa Antibody-drug Conjugates Sales by Type (2015-2020) (Kg)
Table 90. Middle East and Africa Antibody-drug Conjugates Sales Market Share by Type (2015-2020)
Table 91. Middle East and Africa Antibody-drug Conjugates Sales by Application (2015-2020) (Kg)
Table 92. Middle East and Africa Antibody-drug Conjugates Sales Market Share by Application (2015-2020)
Table 93. Middle East and Africa Antibody-drug Conjugates Sales by Countries (2015-2020) (Kg)
Table 94. Middle East and Africa Antibody-drug Conjugates Sales Market Share by Countries (2015-2020)
Table 95. Middle East and Africa Antibody-drug Conjugates Revenue by Countries (2015-2020) (Million US$)
Table 96. Middle East and Africa Antibody-drug Conjugates Revenue Market Share by Countries (2015-2020)
Table 97. ImmunoGen Company Details
Table 98. ImmunoGen Description and Business Overview
Table 99. ImmunoGen Antibody-drug Conjugates Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 100. ImmunoGen Antibody-drug Conjugates Sales Growth Rate (2015-2020)
Table 101. ImmunoGen Antibody-drug Conjugates Sales Market Share in Global Market
Table 102. ImmunoGen Recent Development
Table 103. Seattle Genetics Company Details
Table 104. Seattle Genetics Description and Business Overview
Table 105. Seattle Genetics Antibody-drug Conjugates Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 106. Seattle Genetics Antibody-drug Conjugates Sales Growth Rate (2015-2020)
Table 107. Seattle Genetics Antibody-drug Conjugates Sales Market Share in Global Market
Table 108. Seattle Genetics Recent Development
Table 109. Roche Company Details
Table 110. Roche Description and Business Overview
Table 111. Roche Antibody-drug Conjugates Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 112. Roche Antibody-drug Conjugates Sales Growth Rate (2015-2020)
Table 113. Roche Antibody-drug Conjugates Sales Market Share in Global Market
Table 114. Roche Recent Development
Table 115. Takeda Company Details
Table 116. Takeda Description and Business Overview
Table 117. Takeda Antibody-drug Conjugates Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 118. Takeda Antibody-drug Conjugates Sales Growth Rate (2015-2020)
Table 119. Takeda Antibody-drug Conjugates Sales Market Share in Global Market
Table 120. Takeda Recent Development
Table 121. Antibody-drug Conjugates Distributors List
Table 122. Antibody-drug Conjugates Customers List
Table 123. Global Antibody-drug Conjugates Sales Forecast 2021-2026 (Kg) & (Million US$)
Table 124. Global Antibody-drug Conjugates Sales Forecast by Type 2021-2026 (Kg)
Table 125. Global Antibody-drug Conjugates Sales Forecast by Application 2021-2026 (Kg)
Table 126. Global Antibody-drug Conjugates Sales Forecast by Regions 2021-2026 (Kg)
Table 127. Global Antibody-drug Conjugates Revenue Forecast by Regions 2021-2026 (Million US$)
Table 128. North America Antibody-drug Conjugates Sales Forecast by Countries 2021-2026 (Kg)
Table 129. North America Antibody-drug Conjugates Revenue Forecast by Countries 2021-2026
Table 130. Europe Antibody-drug Conjugates Sales Forecast by Countries 2021-2026 (Kg)
Table 131. Europe Antibody-drug Conjugates Revenue Market Share Forecast by Countries 2021-2026
Table 132. Asia Pacific Antibody-drug Conjugates Sales Forecast by Regions 2021-2026 (Kg)
Table 133. Asia Pacific Antibody-drug Conjugates Revenue Forecast by Regions 2021-2026 (Million US$)
Table 134. Latin America Antibody-drug Conjugates Sales Forecast by Countries 2021-2026 (Kg)
Table 135. Latin America Antibody-drug Conjugates Revenue Forecast by Countries 2021-2026 (Million US$)
Table 136. Middle East and Africa Antibody-drug Conjugates Sales Forecast by Regions 2021-2026 (Kg)
Table 137. Middle East and Africa Antibody-drug Conjugates Revenue Forecast by Regions 2021-2026 (Million US$)
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibody-drug Conjugates Product Picture
Figure 2. Global Antibody-drug Conjugates Sales Market Shar by Type 2015-2026
Figure 3. Adcetris Figures
Figure 4. Kadcyla Figures
Figure 5. Global Antibody-drug Conjugates Sales Market Share by Application in 2019 & 2026
Figure 6. Breast Cancer Use Case
Figure 7. Lymphoma Use Case
Figure 8. Antibody-drug Conjugates Report Years Considered
Figure 9. Global Antibody-drug Conjugates Market Size 2015-2026 (Million US$)
Figure 10. Global Antibody-drug Conjugates Sales 2015-2020 (Kg)
Figure 11. Global Antibody-drug Conjugates Market Size Market Share by Regions 2015-2020
Figure 12. Global Antibody-drug Conjugates Sales Market Share by Regions in 2019
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Antibody-drug Conjugates Sales Share by Manufacturers in 2019
Figure 15. The 5 and 10 Largest Manufacturers in the World: Market Share by Antibody-drug Conjugates Sales in 2019
Figure 16. Antibody-drug Conjugates Value Share by Manufacturers in 2019
Figure 17. Antibody-drug Conjugates Revenue Share by Manufacturers In 2019
Figure 18. Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Antibody-drug Conjugates Revenue Share by Type (2015-2020)
Figure 20. Global Antibody-drug Conjugates Revenue Growth Rate by Type in 2015 & 2019
Figure 21. Global Antibody-drug Conjugates Market Share by Price Range (2015-2020)
Figure 22. Global Antibody-drug Conjugates Revenue Share by Application (2015-2020)
Figure 23. Global Antibody-drug Conjugates Revenue Growth Rate by Application in 2015 & 2019
Figure 24. North America Antibody-drug Conjugates Revenue Growth Rate 2015-2020 (Million US$)
Figure 25. U.S. Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 26. Canada Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 27. Europe Antibody-drug Conjugates Revenue Growth Rate 2015-2020 (Million US$)
Figure 28. Germany Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 29. France Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 30. U.K. Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 31. Italy Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 32. Russia Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 33. Asia Pacific Antibody-drug Conjugates Revenue Growth Rate 2015-2020 (Million US$)
Figure 34. China Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 35. Japan Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 36. South Korea Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 37. India Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 38. Australia Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 39. Taiwan Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 40. Indonesia Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 41. Thailand Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 42. Malaysia Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 43. Philippines Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 44. Vietnam Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 45. Latin America Antibody-drug Conjugates Revenue Growth Rate 2015-2020 (Million US$)
Figure 46. Mexico Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 47. Brazil Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 48. Argentina Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 49. Middle East and Africa Antibody-drug Conjugates Revenue Growth Rate 2015-2020 (Million US$)
Figure 50. Turkey Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 51. Saudi Arabia Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 52. U.A.E Antibody-drug Conjugates Sales Growth Rate (2015-2020) (Kg)
Figure 53. ImmunoGen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Seattle Genetics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Antibody-drug Conjugates Value Chain
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. North America Antibody-drug Conjugates Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 61. North America Antibody-drug Conjugates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 62. Europe Antibody-drug Conjugates Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 63. Europe Antibody-drug Conjugates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 64. Asia Pacific Antibody-drug Conjugates Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 65. Asia Pacific Antibody-drug Conjugates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 66. Latin America Antibody-drug Conjugates Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 67. Latin America Antibody-drug Conjugates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 68. Middle East and Africa Antibody-drug Conjugates Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 69. Middle East and Africa Antibody-drug Conjugates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed